{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T09:41:07Z","timestamp":1792402867095,"version":"4.4.0"},"reference-count":35,"publisher":"Ovid Technologies (Wolters Kluwer Health)","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n                    <jats:title>Purpose of review<\/jats:title>\n                    <jats:p>Lyme disease is the most common vector-borne infection in North America, and the incidence continues to rise as the geographic range of Ixodes ticks expands. While most patients can be cured with early antibiotic therapy, Lyme arthritis persists as a challenging late manifestation, with a subset developing postantibiotic inflammatory disease that mimics autoimmune arthritis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Recent findings<\/jats:title>\n                    <jats:p>Recent studies have advanced our understanding of Lyme arthritis. Even after bacterial eradication, in some patients, residual antigens in the synovial fluid can sustain immune activation. Immunologic studies demonstrate specific HLA-DRB1 alleles associated with postantibiotic Lyme arthritis, suggesting a predisposition to chronic inflammation. These findings demonstrate that Lyme arthritis is a complex immune-mediated disorder that bridges infectious and autoimmune mechanisms.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Summary<\/jats:title>\n                    <jats:p>Antibiotic therapy is effective for most patients with Lyme arthritis, but optimal management for patients with postantibiotic Lyme arthritis is still uncertain. Continued research into the pathogenesis of postantibiotic Lyme arthritis will be key to improving diagnostic accuracy, refining treatment algorithms, and preventing chronic morbidity associated with Lyme arthritis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/bor.0000000000001193","type":"journal-article","created":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T07:00:15Z","timestamp":1787727615000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Rheumatological manifestations of Lyme disease and related tick-borne diseases in north America"],"prefix":"10.1097","author":[{"given":"Blerta","family":"Green","sequence":"first","affiliation":[{"name":"Department of Rheumatology, Allergy, and Immunology, Yale School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasmin","family":"Jaber","sequence":"additional","affiliation":[{"name":"Section of Rheumatology, Allergy, and Immunology, Yale School of Medicine, New Haven, Connecticut, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert T.","family":"Schoen","sequence":"additional","affiliation":[{"name":"Section of Rheumatology, Allergy, and Immunology, Yale School of Medicine, New Haven, Connecticut, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,10,20]]},"reference":[{"key":"R1-20261019","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/art.1780200102","article-title":"An epidemic of oligoarticular arthritis in children and adults in three Connecticut communities","volume":"20","author":"Steere","year":"1977","journal-title":"Arthritis Rheum"},{"key":"R2-20261019","doi-asserted-by":"crossref","first-page":"16090","DOI":"10.1038\/nrdp.2016.90","article-title":"Lyme borreliosis","volume":"2","author":"Steere","year":"2016","journal-title":"Nat Rev Dis Primer"},{"key":"R3-20261019","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0140-6736(11)60103-7","article-title":"Lyme borreliosis","volume":"379","author":"Stanek","year":"2012","journal-title":"Lancet"},{"key":"R4-20261019","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.3201\/eid2708.204763","article-title":"Comparison of Lyme disease in the United States and Europe","volume":"27","author":"Marques","year":"2021","journal-title":"Emerg Infect Dis"},{"key":"R5-20261019","doi-asserted-by":"crossref","first-page":"818","DOI":"10.3201\/eid2205.151806","article-title":"Differences in genotype, clinical features, and inflammatory potential of Borrelia burgdorferi sensu stricto Strains from Europe and the United States","volume":"22","author":"Cerar","year":"2016","journal-title":"Emerg Infect Dis"},{"key":"R6-20261019","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1001\/jama.2016.2884","article-title":"Diagnosis treatment and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis: a review","volume":"315","author":"Sanchez","year":"2016","journal-title":"JAMA"},{"key":"R8-20261019","doi-asserted-by":"crossref","first-page":"102765","DOI":"10.1016\/j.jiph.2025.102765","article-title":"The epidemiology and clinical manifestations of anaplasmosis in humans: a systematic review of case reports","volume":"18","author":"Acosta-Espa\u00f1a","year":"2025","journal-title":"J Infect Public Health"},{"key":"R9-20261019","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1080\/14787210.2025.2526843","article-title":"Management of human babesiosis \u2013 approaches and perspectives","volume":"23","author":"Vannier","year":"2025","journal-title":"Expert Rev Anti Infect Ther"},{"key":"R10-20261019","doi-asserted-by":"crossref","first-page":"508","DOI":"10.3390\/tropicalmed8120508","article-title":"Powassan virus infections: a systematic review of published cases","volume":"8","author":"Kakoullis","year":"2023","journal-title":"Trop Med Infect Dis"},{"key":"R11-20261019","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1097\/BOR.0000000000000698","article-title":"Lyme disease: diagnosis and treatment","volume":"32","author":"Schoen","year":"2020","journal-title":"Curr Opin Rheumatol"},{"key":"R12-20261019","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.idc.2015.02.010","article-title":"Epidemiology of Lyme disease","volume":"29","author":"Mead","year":"2015","journal-title":"Infect Dis Clin North Am"},{"key":"R13-20261019","doi-asserted-by":"crossref","first-page":"616","DOI":"10.3201\/eid2702.202731","article-title":"Estimating the frequency of Lyme disease diagnoses United States","volume":"27","author":"Kugeler","year":"2021","journal-title":"Emerg Infect Dis"},{"key":"R16-20261019","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.ss6622a1","article-title":"Surveillance for Lyme disease \u2013 United States","volume":"66","author":"Schwartz","year":"2017","journal-title":"MMWR Surveill Summ"},{"key":"R18-20261019","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.m1041","article-title":"Lyme borreliosis: diagnosis and management","author":"Kullberg","year":"2020","journal-title":"BMJ"},{"key":"R19-20261019","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s11926-019-0857-2","article-title":"Challenges in the diagnosis and treatment of Lyme disease","volume":"22","author":"Schoen","year":"2020","journal-title":"Curr Rheumatol Rep"},{"key":"R20-20261019","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/mus.10337","article-title":"Lyme disease and the peripheral nervous system","volume":"28","author":"Halperin","year":"2003","journal-title":"Muscle Nerve"},{"key":"R21-20261019","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s10096-018-3417-1","article-title":"Clinical spectrum of Lyme disease","volume":"38","author":"Cardenas-de La Garza","year":"2019","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"R22-20261019","doi-asserted-by":"crossref","first-page":"725","DOI":"10.7326\/0003-4819-107-5-725","article-title":"The clinical evolution of lyme arthritis","volume":"107","author":"Steere","year":"1987","journal-title":"Ann Intern Med"},{"key":"R23-20261019","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.3390\/microorganisms13071602","article-title":"Aspects of the immunopathogenesis of Lyme arthritis","volume":"13","author":"Sigal","year":"2025","journal-title":"Microorganisms"},{"key":"R24-20261019","doi-asserted-by":"crossref","first-page":"2774","DOI":"10.1128\/iai.61.7.2774-2779.1993","article-title":"Association of treatment-resistant chronic Lyme arthritis with HLA-DR4 and antibody reactivity to OspA and OspB of Borrelia burgdorferi","volume":"61","author":"Kalish","year":"1993","journal-title":"Infect Immun"},{"key":"R25-20261019","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.idc.2015.02.004","article-title":"Diagnosis and treatment of Lyme arthritis","volume":"29","author":"Arvikar","year":"2015","journal-title":"Infect Dis Clin North Am"},{"key":"R26-20261019","doi-asserted-by":"crossref","first-page":"e184109","DOI":"10.1172\/JCI184109","article-title":"Wider recognition and greater understanding of postinfectious, antibiotic-refractory Lyme arthritis","volume":"134","author":"Steere","year":"2024","journal-title":"J Clin Invest"},{"key":"R27-20261019","doi-asserted-by":"crossref","DOI":"10.1111\/cmi.12992","article-title":"Interferon-gamma production in Lyme arthritis synovial tissue promotes differentiation of fibroblast-like synoviocytes into immune effector cells","volume":"21","author":"Lochhead","year":"2019","journal-title":"Cell Microbiol"},{"issue":"(Suppl 1)","key":"R28-20261019","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1093\/infdis\/jiae126","article-title":"Lyme arthritis: a 50-year journey","volume":"230","author":"Steere","year":"2024","journal-title":"J Infect Dis"},{"key":"R29-20261019","doi-asserted-by":"crossref","first-page":"e1013324","DOI":"10.1371\/journal.ppat.1013324","article-title":"Bacterial and host enzymes modulate the pro-inflammatory response elicited by the peptidoglycan of Lyme disease agent Borrelia burgdorferi","volume":"21","author":"McCausland","year":"2025","journal-title":"PLoS Pathog"},{"key":"R30-20261019","doi-asserted-by":"crossref","first-page":"108804","DOI":"10.1016\/j.isci.2024.108804","article-title":"Borrelia-specific antibody profiles and complement deposition in joint fluid distinguish antibiotic-refractory from -responsive Lyme arthritis","volume":"27","author":"Bowman","year":"2024","journal-title":"iScience"},{"key":"R31-20261019","doi-asserted-by":"crossref","first-page":"e161170","DOI":"10.1172\/JCI161170","article-title":"Autoimmunity to synovial extracellular matrix proteins in patients with postinfectious Lyme arthritis","volume":"133","author":"Kanjana","year":"2023","journal-title":"J Clin Invest"},{"key":"R32-20261019","doi-asserted-by":"crossref","first-page":"e179391","DOI":"10.1172\/JCI179391","article-title":"Disease-specific T cell receptors maintain pathogenic T helper cell responses in postinfectious Lyme arthritis","volume":"134","author":"Dirks","year":"2024","journal-title":"J Clin Invest"},{"key":"R33-20261019","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/art.41562","article-title":"Clinical practice guidelines by the Infectious Diseases Society of America (IDSA), American Academy of Neurology (AAN), and American College of Rheumatology (ACR): 2020 Guidelines for the Prevention, Diagnosis, and Treatment of Lyme Disease","volume":"73","author":"Lantos","year":"2021","journal-title":"Arthritis Rheumatol"},{"key":"R34-20261019","first-page":"e00483","article-title":"A novel single-tier serologic test to diagnose all stages of Lyme disease","volume":"0","author":"Levin","year":"2025","journal-title":"J Clin Microbiol"},{"key":"R37-20261019","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1086\/322669","article-title":"Persistence of immunoglobulin M or immunoglobulin G antibody responses to Borrelia burgdorferi 10\u201320 years after active Lyme disease","volume":"33","author":"Kalish","year":"2001","journal-title":"Clin Infect Dis"},{"key":"R38-20261019","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1016\/j.cmi.2023.09.017","article-title":"Exploring the dynamics of Borrelia burgdorferi sensu lato antibodies\u2014a registry-based study on laboratory data from Sweden and Denmark","volume":"29","author":"Westerholt","year":"2023","journal-title":"Clin Microbiol Infect"},{"key":"R39-20261019","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s10096-021-04334-y","article-title":"Lyme arthritis in Western Europe: a multicentre retrospective study","volume":"41","author":"Corre","year":"2022","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"R41-20261019","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.idc.2022.03.006","article-title":"Lyme Arthritis","volume":"36","author":"Arvikar","year":"2022","journal-title":"Infect Dis Clin North Am"},{"key":"R42-20261019","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1002\/art.39866","article-title":"Autoimmune arthritides, rheumatoid arthritis, psoriatic arthritis, or peripheral spondyloarthritis following Lyme disease","volume":"69","author":"Arvikar","year":"2017","journal-title":"Arthritis Rheumatol"}],"container-title":["Current Opinion in Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/BOR.0000000000001193","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T09:00:14Z","timestamp":1792400414000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/BOR.0000000000001193"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,20]]},"references-count":35,"URL":"https:\/\/doi.org\/10.1097\/bor.0000000000001193","relation":{},"ISSN":["1040-8711","1531-6963"],"issn-type":[{"value":"1040-8711","type":"print"},{"value":"1531-6963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,20]]}}}